Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer. - Lero MW; Morgan JS; Card MA; Zhu LJ; Li J; Li R; Bui QT; Mohlmann E; Shaw LM (BioRxiv : the preprint server for biology, 2026)